Dear Shareholders,
SHL’s first half of 2005 marked by signing of significant telemedicine contracts in Germany and US and divesture of Bikurofe in Israel, which will result in around USD 9 million capital gain in Q3. Financial results
for the period in line with expectations.
Download the full report
